The Nucleic Acid Therapy Accelerator (NATA) is an independent, not-for-profit Medical Research Council (MRC) unit. Our mission is to advance the development of NATs and associated technologies through high-quality science, collaborations and interdisciplinary research. We work with world-leading academics, clinicians, businesses and charities, bringing together a diverse network of expertise, skills and innovative technologies to bridge translational gaps in NAT development. We have the flexibility to focus on new chemical platform development and any disease area or gene target, and the agility to initiate new projects and collaborations quickly. We can also provide training in oligonucleotide therapeutics and knowledge exchange.